Results 131 to 140 of about 50,392 (230)

Time to Go Back to the Original Name

Frontiers in Microbiology, 2017
Robert C. Gallo, Robert C. Gallo, Luc Willems, Luc Willems, Yutaka Tagaya, Yutaka Tagaya   +5 more
doaj   +1 more source

HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients

Several studies suggest that HTLV-1 infection may be associated with a wider spectrum of neurological and clinical manifestations that do not meet diagnostic criteria for HAM.
de Oliveira, Augusto C Penalva, Carolina Rosadas, the HTLV-1 Clinical Definition Working Group, Marcusso, Rosa Maria do Nascimento, Rosadas, Carolina, Casseb, Jorge, Tatiane Assone, the HTLV-1 Clinical Definition Working Group the HTLV-1 Clinical Definition Working Group, Augusto C. Penalva de Oliveira, Folgosi, Victor A, Smid, Jerusa, The Htlv-Clinical Definition Working Group, Victor A. Folgosi, Jorge Casseb, Rosa Maria do Nascimento Marcusso, Michel E. Haziot, Assone, Tatiane, Jerusa Smid, Haziot, Michel E   +18 more
core   +1 more source

Molecular Epidemiology and Phylogenetic Analysis of HTLV-1 in HIV-1-infected Patients in Tehran, Iran. [PDF]

J Med Virol
Abyar S, Mohebbi SR, Hosseini SM, Kazemian S, Sadeghi A, Zali MR.   +5 more
europepmc   +1 more source

CRISPR-mediated excision of HTLV-1 reduces proviral loads in PBMCs from HAM/TSP patients. [PDF]

J Neurovirol
Brancazio S, Khalili K, Jacobson S, Kaminski R.   +3 more
europepmc   +1 more source

Host genetic determinants of HTLV-1 infection outcomes. [PDF]

Immunol Res
Akbarin MM, Farjami Z, Álvarez HR.
europepmc   +1 more source

No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran [PDF]

Iranian Journal of Basic Medical Sciences, 2013
Houshang Rafatpanah, Farhad Fathimoghadam, Majid Shahabi, Iman Eftekharzadeh, Mohammadreza Hedayati-Moghaddam, Narges Valizadeh, Mohsen Tadayon, SeyyedAliakbar Shamsian, Hamidreza Bidkhori, Raheleh Miri, Ali Bazarbachi   +10 more
doaj  

Experiences from Two Decades of HTLV-1/2 Testing in a Low-Prevalence Area in Southern Germany, 2004 to 2024. [PDF]

Viruses
Korn K, Steininger P, Schmidt B, Thoma-Kress AK, Forneck L, Knöll A.   +5 more
europepmc   +1 more source

Women's knowledge, attitudes and practices related to mother-to-child transmission of HTLV-1 in Peru. [PDF]

PLOS Glob Public Health
Macalupu J, Ginocchio F, Paiva A, Cusihuallpa P, Rodríguez-Hurtado D, Mejía-Cordero F, González-Lagos E, Gotuzzo E.   +7 more
europepmc   +1 more source

HTLV-1-associated diseases: a systematic review. [PDF]

Rev Inst Med Trop Sao Paulo
Marcusso RMN, Folgosi VÂ, Oliveira ACP, Casseb J.   +3 more
europepmc   +1 more source

Low Prevalence of Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) in a Hospital Triage Population in Tehran During 2024-2025. [PDF]

Health Sci Rep
Letafati A, Marvi SS, Hosori NA, Molaverdi G, Esfandiari A, Moghadam NA, Siavoshi S, Norouzi M, Mozhgani SH.   +8 more
europepmc   +1 more source